[Translation] A fasting, single-center, randomized, open-label, single-dose, two-formulation, two-sequence, two-cycle, crossover bioequivalence trial of salmeterol and fluticasone inhalation powder in healthy subjects.
在健康受试者中评价空腹状态下,润生药业有限公司生产的沙美特罗替卡松吸入粉雾剂(受试制剂T,规格:50μg/250μg(沙美特罗/丙酸氟替卡松))与Glaxo Wellcome Production生产的沙美特罗替卡松吸入粉雾剂(参比制剂R,规格:50μg/250μg(沙美特罗/丙酸氟替卡松))的生物等效性。
[Translation] Evaluation of salmeterol and fluticasone inhalation powder spray produced by Runsheng Pharmaceutical Co., Ltd. (test preparation T, specifications: 50 μg/250 μg (salmeterol/fluticasone propionate)) under fasting conditions in healthy subjects Bioequivalence with salmeterol and fluticasone propionate inhalation powder produced by Glaxo Wellcome Production (reference preparation R, specification: 50 μg/250 μg (salmeterol/fluticasone propionate)).